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ABSTRACT The nuclear factor of activated T cells
(NFAT) transcription factors are regulated by calcium/
calcineurin signals and play important roles in T cells,
muscle, bone, and neural tissue. NFAT is expressed in
the epidermis, and although recent data suggest that
NFAT is involved in the skin’s responses to ultraviolet
radiation (UVR), the wavelengths of radiation that
activate NFAT and the biological function of UV-
activated NFAT remain undefined. We demonstrate
that NFAT transcriptional activity is preferentially in-
duced by UVB wavelengths in keratinocytes. The de-
rived action spectrum for NFAT activation indicates
that NFAT transcriptional activity is inversely associ-
ated with wavelength. UVR also evoked NFAT2 nuclear
translocation in a parallel wavelength-dependent fash-
ion and both transcriptional activation and nuclear
translocation were inhibited by the calcineurin inhibitor
cyclosporin A. UVR also evoked NFAT2 nuclear trans-
location in three-dimensional skin equivalents. Evi-
dence suggests that COX-2 contributes to UV-induced
carcinogenesis. Inhibiting UV-induced NFAT activation
in keratinocytes, reduced COX-2 protein induction, and
increased UV-induced apoptosis. COX-2 luciferase re-
porters lacking functional NFAT binding sites were less
responsive to UVR, highlighting that NFAT is required
for UV-induced COX-2 induction. Taken together,
these data suggest that the proinflammatory, antiapo-
ptotic, and procarcinogenic functions of UV-activated
COX-2 may be mediated, in part, by upstream NFAT
signaling. Flockhart, R. J., Diffey, B. L., Farr, P. M.,
Lloyd, J., Reynolds, N. J. NFAT regulates induction of
COX-2 and apoptosis of keratinocytes in response to
ultraviolet radiation exposure. FASEB J. 22, 4218–4227
(2008). www.fasebj.org
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The nuclear factor of activated t cells (NFAT)
family of transcription factors was first identified in T cells
and is established as playing a central role in transcription
during immune responses (1). In immune cells, NFAT is
involved in transcription of genes, including interleukin
(IL) -2, -3, -4, -5, -8, and -13; granulocyte-macrophage
colony-stimulating factor (GM-CSF), tumor necrosis fac-
tor  (TNF-), and IFN- (2). NFAT is also functional
in muscle (3, 4), bone (5), skin (6–8), and neural
tissue (9, 10), exerting diverse functions ranging from
embryonic development of cardiac valves (4) to neuro-
nal apoptosis (10). Five members of the NFAT family
have been identified: NFAT1 (NFATp, NFATc2) (11),
NFAT2 (NFAT c, NFATc1) (12), NFAT3 (NFATc4)
(13), and NFAT4 (NFATx) (13, 14), which are all
regulated by the calcium-dependent serine-, threonine-
phosphatase calcineurin, the most recently discovered
NFAT protein, NFAT5 (also named TonEBP) (15, 16),
is not regulated by calcineurin (15).
NFAT is predominantly located in an inactive hyper-
phosphorylated state in the cytoplasm (17). Increased
concentration of intracellular calcium ([Ca2]i) acti-
vates calcineurin that dephosphorylates NFAT (17),
evoking nuclear translocation where NFAT is able to
drive gene transcription in cooperation with other
transcription factors, including AP-1 (18). NFAT-de-
pendent gene transcription halts when [Ca2]i de-
creases and NFAT translocates back to the cytoplasm
following rephosphorylation by NFAT kinases (19),
including glycogen synthase kinase-3 (GSK-3) (20–22)
and casein kinase-1 (CK-1) (23, 24).
Ultraviolet radiation (UVR) is a potent environmental
carcinogen. The radiation emitted by the sun can be
divided into three main regions: ultraviolet, visible, and
infrared, collectively termed optical radiation (25). UVR
comprises wavelengths from 100 to 400 nm, which are
further divided into three main wavebands: UVA (400–
315 nm), UVB (315–280 nm), and UVC (280–100 nm)
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(25). Effects of UVR on skin range from mild inflamma-
tion and erythema to hyperplasia, burns, photoageing,
and cutaneous malignancies (26). DNA mutations result-
ing from chronic exposure to sunlight and UVB radia-
tion, in particular, are regarded as a major risk factor for
nonmelanoma skin cancer (27–29). DNA mutations
caused by UVA likely arise indirectly via oxidative stress or
by photosensitisation reactions through absorption of
UVA by unidentified chromophores (28). Conversely,
UVR is used therapeutically for treatment of skin disor-
ders, including psoriasis and atopic eczema (30). In the
case of psoriasis, successful clearing is wavelength depen-
dent, with UVB radiation being most effective in unsensi-
tized skin (31, 32). It is, therefore, important to consider
wavelength-specific responses and employ biologically rel-
evant wavelengths and doses when investigating biological
responses to UVR. Investigating the molecular targets of
UVR and the signal transduction pathways activated by
UVR will increase understanding of both detrimental and
therapeutic effects.
It has recently been shown that UVA increases DNA-
binding of NFAT2 in human fibroblasts (33) and that
UVB/UVC radiation activates NFAT in a mouse cell line
and in mouse skin in vivo (34). Solar UVC radiation is
absorbed by the atmospheric ozone layer and does not
present an environmental hazard. To date, there has been
no comparison of the ability of different, physiologically
relevant wavelengths to activate NFAT and biological
functions of UV-activated NFAT are poorly understood.
Cyclooxygenases, of which there are two isoforms,
are enzymes involved in conversion of arachidonic acid
to prostaglandins (PGs). COX-1 is expressed constitu-
tively in most tissues and is a housekeeping enzyme.
COX-2 is expressed at undetectable/low levels in nor-
mal, non-neoplastic tissue, but increased COX-2 expres-
sion has been reported during inflammation and
in precancerous lesions and neoplasms (35–38). In-
creased COX-2 activity enhances migration, angiogen-
esis, and apoptotic resistance, which are well recog-
nized traits of cancer progression (35, 36). UVR
increases COX-2 expression in cultured human kera-
tinocytes (39) and COX-2 protein levels become ele-
vated in the epidermis of human skin following UVB
irradiation and also in squamous cell carcinomas and
actinic keratoses (39). Pharmacological inhibition of
COX-2 has been shown to reduce epidermal PG con-
tent and tumor development in mice chronically irra-
diated with UVB (40). A recent study of heterozygous
COX-2 knockout mice showed that COX-2 is required
for the development of UV-induced skin tumors (41),
and COX-2 knockout mice displayed increased UV-
induced apoptosis in the epidermis (41). The COX-2
promoter contains binding sites for several transcrip-
tion factors, including NFAT (42). The role of NFAT in
UV-induced COX-2 induction has not been investi-
gated, and the role played by NFAT in UV-driven
apoptosis in skin is not understood.
We demonstrate that UVR increases NFAT transcrip-
tional activity and evokes nuclear translocation of
NFAT2 in a wavelength-dependent fashion in HaCaT
keratinocytes. The action spectrum for NFAT activation
was derived, which highlighted that NFAT transcrip-
tional activation by UVR is inversely associated with
wavelength. NFAT is required for both maximal UV-
induced activation of the COX-2 promoter and induc-
tion of COX-2 protein. Inhibiting activation of NFAT
using cyclosporin A (CsA) also increased apoptosis of
keratinocytes following UV irradiation. Taken together,
these data suggest that the proinflammatory and pro-
carcinogenic role played by COX-2 in response to UVR
may be mediated, in part, by upstream NFAT signaling.
MATERIALS AND METHODS
Cell culture and epidermal equivalents
Retroviral phoenix amphotropic (RPA) cells were a gift from
G. Nolan (Stanford University, Palo Alto, CA, USA). HaCaT
keratinocytes, a spontaneously immortalized keratinocyte cell
line, were a gift from N. E. Fusenig (German Cancer Research
Centre, Heidelberg, Germany). HaCaTs and RPA cells were
cultured in Dulbecco’s modified Eagle medium (Lonza,
Basel, Switzerland) supplemented with 10% fetal bovine
serum, penicillin, and streptomycin in a humidified incuba-
tor at 37°C/5% CO2. Full thickness epidermal equivalents
(FTEs) were purchased from Mattek (Ashland, MA, USA).
UV irradiation
Cells were irradiated in multiwell culture plates and prior to
irradiation, culture medium was removed and replaced with
PBS. After irradiation, the PBS was replaced with fresh medium.
For experiments using CsA (Calbiochem, Gibbstown, NJ, USA),
cells were incubated with 5 or 10 M CsA for 16 h prior to
irradiation. Lamps used were as follows (shorthand name and
percentage of UVB emitted is shown in parentheses): Philips TL
20W/12 RS (TL-12, 53% UVB), Philips TL 20W/01 RS (TL-01,
79% UVB), Helarium R1.01 (Helarium, 16% UVB) and He-
larium B1-12-40W (Arimed B, 4% UVB). Arimed B lamps
provided the closest spectral match to natural sunlight in this
study. The irradiance of all lamps was checked before each
experiment using a calibrated photoradiometer. All UVR doses
administered were biologically relevant in terms of erythemo-
genic capacity and ranged from 0.7–8.4 SED (standard erythe-
mal dose). One SED is equivalent to an erythemal effective
radiant exposure of 100 J/m2 normalized (according to the
erythema action spectrum) at 297 nm. An exposure dose of 4
SED would be expected to induce moderate erythema on
unacclimated white skin but minimal or no erythema on previ-
ously exposed skin (25).
Luciferase assays
NFAT transcriptional activity was measured using an NFAT
luciferase reporter [p(NFAT)3-luc] (43) containing three re-
peats of the NFAT/AP-1-binding site from the murine IL-2
promoter (a gift from D. J. McKean, Mayo Foundation, Roches-
ter, MN, USA). COX-2 luciferase reporters (gifts from M. A.
Iniguez, Centro de Biologia Molecular, Madrid, Spain) contain-
ing either wild-type or mutated NFAT binding sites were used to
assess the requirement of NFAT in COX-2 induction. The
reporters have been described previously (42) but briefly,
P-1900 contains the complete human COX-2 promoter, and the
other reporters are derivatives of this, with binding site muta-
tions as follows. The plasmid P-274 lacks NF-B binding sites.
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The other COX-2 reporter plasmids are mutants derived from
P-274 that lack either the distal NFAT binding site (P-dNFAT-
mut), the proximal site (P-pNFAT-mut), or both sites (P-d/
pNFAT-mut). In all luciferase experiments, transfection effi-
ciency and cell viability were controlled for by cotransfecting a
Renilla luciferase control vector (pRLTK; Promega, Southamp-
ton, UK), and reporter firefly luciferase values were normalized
to the Renilla values. Luciferase assays were performed using the
dual luciferase assay system (Promega). For UV experiments,
cells were seeded in 24-well culture plates and transfected with
0.5 g of firefly reporter plus 0.025 g of Renilla control using
Lipofectamine and Plus reagents (Invitrogen, Paisley, UK),
according to the manufacturer’s instructions. The following day,
cells were irradiated as described then lysed at the desired time
point post-UV.
Action spectrum
The NFAT action spectrum was derived by a process of
mathematical induction exploring three candidate models; a
Gaussian function, a single exponential function of wave-
length, and a function representing the sum of 2 exponen-
tials. An optimization solution for each model was derived
using the SOLVER facility in Excel (http://www.solver.
com/), where it was found that a function representing the
sum of 2 exponentials provided the closest match between
the observed reciprocal dose for a given end point and that
calculated using the model. The basis of the induction
approach is to estimate an action spectrum that is described
by fewer parameters than the number of sources used,
calculate the weighted dose for an appropriate end point
(increased NFAT transcriptional activity of 3-fold) and com-
pare these calculated doses with those actually observed. The
optimization process involves repeated adjustment of the various
parameters until the closest agreement between the calculated
and the observed values is achieved. The action spectrum for
healing of psoriasis patients using psoralens plus UVA photo-
chemotherapy (PUVA) was defined using this process (44)
and mathematical induction (although a slightly different
method) was also applied to derive a candidate action spec-
trum for skin cancer induction by UVR (27).
Retroviral transduction
Human NFAT2 cDNA was cloned from pEGFPc1-NFAT2 (45)
[a gift from D. Cantrell, Imperial Cancer Research Fund
(ICRF), London, UK] into the retroviral vector pLEGFPc1
(Clontech, Saint-Germain, France) using BspEI and HindIII
restriction sites. The pLEGFP-NFAT2 and pLEGFP-empty
(control) vector were transfected into the RPA packaging cell
line and stable, viral-producing cell lines were obtained by
selection using G418 (Invitrogen). Cells were then trans-
ferred to an incubator at 32°C for virus production. Target
cells were seeded in multiwell culture plates, virus was added
to each well plus 5 g/ml polybrene (Sigma), and cells were
transduced by centrifuging plates at 1500 rpm for 1.5 h using
a Sanyo, Harrier 15/80 centrifuge (Sanyo Gallenkamp,
Loughborough, UK).
GFP-NFAT2 imaging and immunostaining
For GFP-NFAT2 imaging experiments, cells were seeded on
glass coverslips and retrovirally transduced with GFP-NFAT2
as described. Cells were then incubated for 48 h after
transduction to allow for expression, and then cells were
irradiated as described. Following irradiation, cells were fixed
with 4% paraformaldehyde in PBS for 15 min at room
temperature (RT). Cells were then washed with PBS and
mounted onto glass slides using Vectashield (Vector Labs,
Peterborough, UK).
Immunostaining for endogenous NFAT2 in HaCaTs was
performed using an antibody that binds to the N terminus of
human NFAT2 (46) (a gift from N. Rice, Molecular Basis of
Carcinogenesis Laboratory, Frederick, MD, USA). NFAT2
expression in skin equivalents was detected using an NFAT2
antibody, clone 7A6 (BD Biosciences, Oxford, UK). Cells
were seeded, irradiated, and fixed, as detailed above. Follow-
ing fixation, cells were permeabilized with 0.2% Triton-X
(Sigma) in PBS, then blocked with 1% goat serum in PBS for
20 min, blocked with avidin D/biotin solutions (Vector Labs),
then incubated at RT for 1 h with the NFAT2 antibody
(1:100). Cells were then incubated with biotinylated anti-
rabbit antibody (1:300; Vector Labs) for 1 h at RT, then
incubated with streptavidin-Oregon Green 488 (Molecular
Probes, Invitrogen) at 1:300 dilution for 30 min. Finally, cells
were treated with 0.1M TOTO-3 (Molecular Probes, Invitro-
gen), then mounted onto glass slides using Vectashield
Figure 1. Ultraviolet radiation increases NFAT transcriptional
activity: derivation of the NFAT action spectrum. A) NFAT
luciferase activity was measured 24 h after UV irradiation with
one of four different UV sources. All UV sources evoked a
dose-dependent increase in NFAT transcriptional activity,
with TL-12 lamps (53% UVB) being most effective. Values are
means  se from 3 independent experiments performed in
triplicate. B) The action spectrum for NFAT was derived from
the above luciferase data by a process of mathematical
induction exploring three candidate models (see Materials
and Methods). NFAT activity is inversely associated with
wavelength. The action spectra for erythema (47) and general
DNA damage (29) are shown for reference.
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(Vector Labs). Cells were washed 3 times after each incuba-
tion. FTEs were frozen in liquid nitrogen, mounted using
optimal cutting temperature (OCT) compound, and cut into
6-m sections using a cryostat before attachment onto glass
slides. Sections were fixed in 4% paraformaldehyde, and
staining was performed as described above. All microscopy
was performed using a Leica TCS SP II laser scanning
confocal microscope (Leica Microsystems, Heidelberg, Ger-
many). Imaging data were quantified using LCS Lite 2.61
software (Leica Microsystems) using regions of interest tools.
The cytoplasmic and nuclear fluorescence values from each
cell were quantified and the nuclear:cytoplasmic ratio for
each cell was calculated.
Western blot analysis
Cell were lysed in buffer containing: 100 mM Tris-HCl (pH
7.4), sodium chloride (100 mM), sodium fluoride (25 mM),
benzamidine (1 mM), EDTA (2 mM), sodium orthovanadate
(0.1 mM), Triton-x100 (0.1%) plus a protease inhibitor
cocktail (Sigma, P8340–1ML). Samples were probe sonicated
for 2 5 s pulses at an amplitude of 10 m. For electrophore-
sis, samples were combined with 4 sample buffer contain-
ing: 0.25M Tris-HCl (pH 8.0), 8% SDS, 40% glycerol, 10%
-mercaptoethanol, and bromphenol blue. Samples were
then heated for 3 min at 90°C immediately prior to electro-
phoresis using 4–20% Novex Tris-glycine precast gels (In-
vitrogen). Samples were loaded (40 g/well) and stacked at
100 V for 	30 min followed by electrophoresis at 150 V for
	1.5 h. Running buffer contained: 3.03 g/L Tris base, 14.42
g/L glycine and 1 g/L SDS, pH 8.5. Protein was then
transferred to PVDF membrane (Amersham Biosciences, NY,
USA) at 100 V for 1 h using buffer consisting of: 3.0 g/L
Tris-base, 14.4 g/L glycine, 20% methanol and 0.1% SDS.
Membranes were blocked with 5% nonfat milk in TBS/T
for 1 h at RT. COX-2 antibody (1:100) (Santa Cruz Biotech-
nology, Santa Cruz, CA, USA; sc-19999) in TBS/T  1% milk
was incubated on the membrane for 1 h at RT. Horseradish
peroxidase (HRP) -tagged secondary antibody (Upstate Bio-
technology, Lake Placid, NY, USA) was applied at 1:2000 in
TBS/T  1% milk for 1 h at RT. Equal protein loading was
confirmed by blotting for -actin using a mouse anti-human
-actin antibody (Sigma) diluted at 1:10000 in TBS/T  5%
milk and incubated at RT for 45 min. The -actin signal was
detected using an anti-mouse HRP-tagged secondary antibody
(Upstate Biotechnology) as described above. Signals were
detected using ECL Plus reagent (Amersham), according to
the manufacturer’s instructions. Membranes were imaged
using a Fujifilm FLA-3000 fluorescent image analyzer.
Annexin V/7-amino-actinomycin D (7AAD) apoptosis assay
UV-induced apoptosis was studied by labeling cells with
phycoerytherin-tagged (PE) Annexin V and the DNA dye
7AAD (both from BD Biosciences). Following irradiation,
cells were trypsinized and washed with PBS. A master mix
consisting of Annexin V binding buffer, Annexin V-PE, and
7AAD was made and 300 l was added to each sample such
that each sample was incubated with 300 l buffer  0.5 l
Annexin V-PE and 0.5 l 7AAD. Samples were incubated in
staining mix for 15 min prior to flow cytometry. Fifteen
thousand cells per sample were analyzed using a FACScan
flow cytometer (BD Biosciences) operating Cell Quest Pro
software. Data were analyzed using Win MDI 2.8 (Scripps
Institute, La Jolla, CA, USA).
Statistical analysis
Statistical analysis was performed using GraphPad Prism
version 4.00 for Windows (GraphPad, San Diego CA, USA).
RESULTS
UVR-induced transcriptional activation of NFAT is
wavelength dependent
Transcriptional activity of NFAT was dose-dependently
increased by all UV sources employed, and UVB-biased
Figure 2. UVR evokes wavelength-dependent nuclear translocation of GFP-NFAT2. Cells were retrovirally transduced with virus
transmitting GFP-NFAT2 prior to irradiation. A, C) Images show nuclear translocation 24 h after irradiation. Arimed B
irradiation (A) (12,310 mJ/cm2) and TL-12 irradiation (C) (62 mJ/cm2) evoke nuclear translocation of GFP-NFAT2.
B, D) Quantification of nuclear translocation by calculating nuclear:cytoplasmic ratio of GFP-NFAT2 following Arimed B
irradiation (B) and TL-12 irradiation (D). Values are means se from at least 12 fields of view (90 cells in total) obtained from
3 independent experiments. Negative controls (–ve) were mock irradiated, and positive controls (ve) were treated with 1 M
ionomycin. ***P 
 0.001 vs. negative control; one-way ANOVA. Scale bar  50 m.
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sources were better activators of NFAT compared to
UVA-biased sources (Fig. 1A). The total UV dose
required to increase NFAT activity 3-fold using
Arimed B lamps (94% UVA) was 239 times greater
than that required when using TL-12 lamps (53%
UVB). From the data in Fig. 1A, the action spectrum
for NFAT was derived, which illustrates that NFAT
transcriptional activity is inversely associated with
wavelength (Fig. 1B). The action spectrum for NFAT
is distinct from the action spectra for erythema (47)
and DNA damage (29).
UVR-induced nuclear translocation of NFAT2 is
wavelength dependent
NFAT translocation in response to UVR was examined
by immunostaining for endogenous NFAT and by
imaging of GFP-tagged NFAT2 following irradiation
with Arimed B and TL-12 lamps. Translocation of
GFP-NFAT2 was observed with a UV-dose of 62 mJ/
cm2 using TL-12 lamps (Fig. 2C, D), whereas transloca-
tion following Arimed B irradiation required a UV-dose
of 12,310 mJ/cm2 (Fig. 2A, B). Figure 3 depicts a
similar response when investigating the localization of
endogenous NFAT2 by immunostaining. A significant
increase in the nuclear:cytoplasmic ratio of NFAT2 was
achieved by irradiating cells with 6155 mJ/cm2 using
Arimed B lamps, whereas a significant increase was seen
with TL-12 lamps at a UV dose of 62 mJ/cm2.
CsA inhibits UV-induced activation of NFAT
To assess the involvement of calcineurin and to validate
an NFAT inhibitor for use in functional studies, cells
were treated with the calcineurin inhibitor CsA prior to
irradiation. Pretreating cells with 5 or 10 M CsA
prevented UV-induced nuclear translocation of GFP-
NFAT2 (Fig. 4A, B). Pretreating cells with 5 M CsA
also reduced UV-induced NFAT transcriptional activa-
tion (Fig. 4C). Subsequently, CsA was used to assess the
function of UV-activated NFAT.
NFAT is required for COX-2 induction by UVR
The COX-2 promoter contains two NFAT binding sites
(Fig. 5A), and it is known that NFAT is essential for
activation of the COX-2 promoter in T cells (42). We
investigated involvement of NFAT in UV-induced
COX-2 induction using COX-2 luciferase reporters that
selectively lacked NFAT binding sites. COX-2 lucif-
erase reporter assays indicate that the proximal and
distal NFAT binding sites in the COX-2 promoter are
required for maximal induction of the COX-2 pro-
moter by UVR (Fig. 5B). Both Arimed B and TL-12
lamps induced activation of the reporter containing
the complete COX-2 promoter (p1900). Interest-
ingly, COX-2 promoter activity was induced more by
TL-12 lamps than Arimed B lamps, and this wave-
length-dependence parallels that of NFAT induction.
UV-induced activity of the reporter lacking the distal
NFAT binding site (dmut) did not differ compared
to p274. UV-induced activity of the reporter lacking
the proximal NFAT binding site (pmut), and the
reporter lacking both distal and proximal sites (d/
pmut) was significantly reduced compared to p274.
This indicates that functional NFAT binding sites are
required for maximal induction of the COX-2 pro-
moter by UVR.
The involvement of NFAT in UV-induced COX-2
protein induction was assessed by treating cells with
CsA prior to irradiation. Induction of COX-2 protein by
Arimed B lamps was effectively blocked when cells were
pretreated with 5 or 10 M CsA (Fig. 5C). Taken
together with the COX-2 promoter data (Fig. 5B), this
illustrates that NFAT is involved in UV-induced COX-2
induction.
Figure 3. UVR evokes wavelength-dependent nuclear translo-
cation of endogenous NFAT2. Cells were fixed 24 h after UV
irradiation and immunostained for detection of endogenous
NFAT2. A) Images represent the effect of UVR on endoge-
nous NFAT2 localization 24 h after irradiation with Arimed B
or TL-12 lamps. Digital zoom images are also included for
clarity. B) Quantification of nuclear translocation by calculat-
ing nuclear:cytoplasmic ratio of NFAT2. Values are means 
se from 8 fields of view (161 cells in total) obtained from
3 independent experiments. Negative controls (–ve) were
mock irradiated. **P 
 0.01, ***P 
 0.001 vs. negative
control; one-way ANOVA. Scale bars  50 m.
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Inhibiting NFAT activation with CsA increases
UV-induced apoptosis
Apoptosis was quantified 24 h after irradiation in the
presence or absence of doses of CsA shown to inhibit
UV-induced activation of NFAT (Fig. 4). Irradiating
cells with 12,310 mJ/cm2 using Arimed B lamps in-
duced around 30% apoptosis that increased to	40 and
	55% when cells were pretreated with 5 or 10 M CsA,
respectively (Fig. 6A, C). Irradiating cells with 62 mJ/
cm2 using TL-12 lamps induced 40% apoptosis com-
pared to 55 and 75% when cells were pretreated with 5
or 10 M CsA, respectively (Fig. 6D, F). Early apoptotic
populations were also similarly increased by CsA pre-
treatment (Fig. 6B, E; Arimed B and TL-12, respec-
tively). CsA alone did not induce apoptosis (data not
shown). These data show that inhibiting UV-induced
activation of NFAT with CsA increases UV-induced
apoptosis, suggesting an antiapoptotic role for UV-
activated NFAT. Furthermore, doses of CsA (i.e., 1 M)
that were not sufficient to reduce UV-induced NFAT
activation did not alter the amount of apoptosis in-
duced by UVR (data not shown).
UVR induces NFAT2 nuclear translocation in a
full-thickness epidermal equivalent model
Full-thickness epidermal equivalents (FTEs) display
in vivo-like morphological and growth characteristics
and provide an excellent in vitro tool for studying
biological responses in skin. NFAT2 was located in the
cytoplasm of keratinocytes in untreated FTEs, and no
cells stained positively for nuclear NFAT2 (Fig. 7). FTEs
were irradiated with 6155 and 12,310 mJ/cm2 using
Arimed B lamps and 124 mJ/cm2 using TL-12 lamps
then fixed 24 h later. Irradiating cells with 6155 mJ/
cm2 using Arimed B lamps did not induce NFAT2
nuclear translocation, whereas 12,310 mJ/cm2 Arimed
B and 124 mJ/cm2 TL-12 irradiation evoked the ap-
pearance of cells staining positively for nuclear NFAT2
(Fig. 7).
DISCUSSION
Because wavelength is an integral factor that contrib-
utes to responses evoked by UVR, we focused particu-
larly on the wavelength dependence of NFAT re-
sponses. UVR sources that exhibit a high ratio of UVB
to total UVR, activated NFAT at much lower doses than
lamps with a low ratio (and correspondingly high ratio
of UVA to total UVR). The derived action spectrum for
NFAT shows that NFAT activity is inversely associated
with wavelength. Notably, the action spectrum for
NFAT activation is distinct from the action spectra for
erythema (47) and DNA damage (29). This implies that
the chromophore for NFAT activation is not DNA and
that it is also different from the (unknown) chro-
mophore that is the principal trigger for erythema. It
was shown prior to commencement of this study that
UVB and UVC increased NFAT transcriptional activity
in a mouse cell line and in mice in vivo (34). However,
UVC is not physiologically important in the context of
environmental solar exposure, and we are the first to
compare the ability of physiologically relevant wave-
lengths to activate NFAT.
Since there are four calcineurin-regulated NFATs, we
investigated the cellular localization of different NFAT
proteins. GFP-NFAT2 translocates to the nucleus fol-
lowing irradiation with 62 mJ/cm2 TL-12 irradiation,
whereas 12,310 mJ/cm2 is required when using Arimed
B lamps. This highlights that nuclear translocation
parallels the NFAT transcriptional data, and this obser-
vation was also similar for endogenous NFAT2. Inter-
estingly, UVR did not evoke nuclear translocation of
NFAT1, 3, or 4 (data not shown), and it appears that
NFAT2 is the principal NFAT isoform activated by
UVR. Isoform-specific activation of NFAT proteins has
also been described elsewhere (48, 49), and this may be
Figure 4. CsA inhibits UV-induced GFP-NFAT2 nuclear translocation and NFAT transcriptional activation. A) Cells retrovirally
transduced with virus transmitting GFP-NFAT2 were treated with either vehicle or 5 or 10 M CsA for 16 h prior to UV
irradiation or ionomycin (1 M) treatment. Images show nuclear translocation 24 h after irradiation or ionomycin treatment.
B) Quantification of nuclear translocation by calculating nuclear:cytoplasmic ratio of GFP-NFAT2. Values are means  se from
8 fields of view (90 cells in total) obtained from 3 independent experiments. C) Cells were treated with either vehicle or 5 M
CsA 16 h prior to UV irradiation or TPA/ionomycin (TPA/iono) treatment, and NFAT luciferase activity was measured 24 h
later. Values are means  se from 3 independent experiments performed in triplicate. **P 
 0.01, ***P 
 0.001 vs. vehicle
control; one-way ANOVA.
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due to differences in the regulatory regions between
NFAT proteins.
NFAT2 nuclear translocation in epidermal equiva-
lents was also preferentially induced by UVB wave-
lengths. Irradiating epidermal equivalents with 6155
mJ/cm2 (3.5 SED) using Arimed B lamps did not
induce an appearance of cells staining positively for
nuclear NFAT2, whereas this was achieved by 124
mJ/cm2 (3.1 SED) TL-12 irradiation. Arimed B lamps
(	4% UVB) were able to induce NFAT2 nuclear trans-
location when a higher dose was applied (12,310 mJ/
cm2, 7 SED) and notably, this effective dose was around
100 times higher than that required by TL-12 lamps
(	53% UVB), suggesting that UVB wavelengths are
more potent activators of NFAT in epidermal equiva-
lents. Furthermore, when irradiating cells with equally
erythemogenic doses using Arimed B or TL-12 lamps
(3.5 and 3.1 SED, respectively), the lamps that emitted
a higher UVB to UVA ratio (TL-12 lamps) were much
more effective at inducing NFAT2 activation. That
TL-12 lamps were more effective activators of NFAT in
epidermal equivalents than Arimed B lamps, is consis-
tent with data showing that TL-12 lamps are more
effective at inducing NFAT transcriptional activation
and nuclear translocation in cultured keratinocytes
in vitro.
Pretreating cells with CsA (at doses shown to inhibit
UVR-induced NFAT activation) reduced the amount of
COX-2 protein induced by UVR. This suggests an
involvement of NFAT in UVR-driven induction of
COX-2, and this was confirmed by COX-2 luciferase
reporter experiments. The human COX-2 promoter
contains binding sites for NF-B, NF-IL6, CRE binding
proteins, and NFAT (42). There are two NFAT binding
sites in the COX-2 promoter denoted the distal- and
proximal-NFAT binding sites that lie at regions115 to
83 and 90 to 47, respectively. The reporter lack-
ing the distal site did not respond differently compared
to the control reporter containing both NFAT binding
sites, whereas the reporter lacking the proximal site
displayed significantly reduced activity compared to the
control plasmid following UV radiation. The reporter
lacking both the distal and proximal sites was not
induced by UVR. This suggests that the proximal site
may be more important for driving COX-2 in response
to UVR and that the distal site may serve to support or
enhance the activity of the proximal site. The distal
NFAT site has been described as a “pure site,” which
binds NFAT in the absence of other factors, whereas
the proximal NFAT binding site lies adjacent to an AP-1
binding site (42). It is known that UVR induces AP-1
complex formation (26) and that NFAT and AP-1 often
bind DNA in cooperation with each other (18). It is
likely that UV-induced NFAT and AP-1 both bind the
proximal NFAT binding site in the COX-2 promoter,
thus accounting for the apparent increased primary
importance of the proximal NFAT site. It was also
observed that the reporter vector lacking the NF-B
elements (P-274) was induced to a lesser extent by UVR
than the complete reporter (P-1900), suggesting in-
volvement of NF-B. In addition, we show that NFAT is
involved in induction of COX-2 by UVR and it is likely
that several elements, including NFAT, NF-B, and
CRE are required for maximal induction of COX-2 by
Figure 5. NFAT is involved in UV-induced activation of the
COX-2 promoter and UV-induced COX-2 protein produc-
tion. A) Schematic diagram of the human COX-2 promoter
and the promoters of COX-2 luciferase reporters used
(adapted from ref. 42). B) COX-2 promoter activity 24 h after
UV irradiation was measured by transfecting cells with lucif-
erase reporter vectors that selectively lacked either one or
both of the NFAT binding sites present in the COX-2
promoter. Positive controls (TPA/iono) were treated with
TPA (50 nM) and ionomycin (1 M). Values are means  se
from 3 independent experiments performed in quadrupli-
cate. C) Western blot analysis of lysates prepared 24 h after
Arimed B irradiation in the presence or absence of 5 or 10
M CsA pretreatment. The two COX-2 bands migrate to 70
and 72 kDa, which are glycosylated variants of COX-2 protein
that have been previously described (64, 65). *P 
 0.05,
***P 
 0.001 vs. control vector containing all NFAT binding
sites (hatched bar); one-way ANOVA. UT, untreated; UV,
UVR only; Vh, vehicle  UVR.
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UVR (50). Our data are further supported by a study
that showed UVB reduced activity of GSK-3 and that
overexpression of GSK-3 reduced COX-2 induction by
UVB (51). GSK-3 is a protein kinase known to be
important in regulating NFAT localization by inhibitory
phosphorylation.
Comparing responses induced by Arimed B and
TL-12 lamps also indicates that UVB wavelengths acti-
vate the COX-2 promoter more than UVA. This sup-
ports findings by Mahns et al. (52), who showed that
induction of COX-2 in an artificial epidermis was
largely UVB driven, and additionally, our data impli-
cates NFAT in this response.
It is known that UVR induces apoptosis of keratino-
cytes, and the apoptotic response is likely to serve as a
protective, anticarcinogenic response that prevents rep-
lication of cells harboring UV-induced DNA mutations.
NFAT plays an antiapoptotic role during cardiomyocyte
hypertrophy (53), in bronchial epithelial cells (54),
and in granule neurons in the developing cerebellum
(9). In our experiments, it was observed that doses of
UVR that induced NFAT activation were also doses that
induced appreciable levels of apoptosis. It was hypoth-
esized that NFAT may be involved in mediating UV-
induced apoptosis either positively or negatively. Pre-
treating HaCaT keratinocytes with doses of CsA shown
to inhibit UV-induced NFAT activation increased the
amount of UV-induced apoptosis, suggesting that UV-
activated NFAT is antiapoptotic. These data support
findings that show inhibiting NFAT with CsA resulted
in decreased fibroblast viability following UV irradiation
(33). Conversely, Yarosh et al. (55) suggest that NFAT
plays a proapoptotic role in response to UVR by present-
ing data that show CsA reduces apoptosis of keratinocytes
(55). However, this response is only seen when adminis-
tering a highly cytotoxic dose of UVR (55). When irradi-
ating cells with a lower dose of UVR, their data clearly
show that CsA decreases viability (55). Our data support
the similar responses found in fibroblasts (33).
Figure 6. Inhibiting NFAT with CsA increases apoptosis in response to UV irradiation. Cells were treated with 5 or 10 M CsA
prior to irradiation. Density plots show that CsA pretreatment dose dependently increased UV-induced apoptosis after both
Arimed B (A) and TL-12 (D) irradiation. The percentage of Annexin V positive/7AAD negative cells (early apoptosis) following
Arimed B (B) and TL-12 (E) irradiation and percentage of Annexin V positive/7AAD positive cells plus Annexin V
positive/7AAD negative cells (total apoptosis) following Arimed B (C), and TL-12 (F) irradiation is summarized in bar charts
that show the mean  se percentage of positive cells from 3 independent, triplicate experiments. ***P 
 0.001 vs. vehicle
(DMSO) control; one-way ANOVA.
Figure 7. UVR evokes NFAT2 nuclear translocation in a skin
equivalent model. Full-thickness epidermal equivalents were
irradiated with 6155 and 12,310 mJ/cm2 using Arimed B
lamps or 124 mJ/cm2 using TL-12 lamps. Specimens were
fixed 24 h after irradiation, and immunostaining for detec-
tion of endogenous NFAT2 was performed. Arrows indicate
positive nuclear staining of NFAT2. Scale bars  50 m.
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In our experiments, CsA was used to inhibit UV-
induced NFAT activation so that the biological function
of UV-activated NFAT could be explored. It is not sug-
gested that CsA per se could be used as an antineoplastic
therapy for skin cancer. Prolonged treatment with CsA as
an immunosuppressant in transplant medicine increases
the chances of developing malignancy (56, 57). Increased
cancer risk is largely attributed to reduced immunosur-
veillance that results from CsA-mediated inhibition of
NFAT signaling in T cells (58). Although down-regulating
NFAT in immune cells has procarcinogenic effects, up-
regulated NFAT signaling in nonimmune cells can often
be linked to a procarcinogenic outcome (59).
Increased NFAT transcriptional activity can contrib-
ute to both carcinoma invasion and migration in vitro
(60), and data suggest that NFAT may promote tumor
progression partly by up-regulating COX-2 (59). In-
creased COX-2 expression in colon carcinoma cells
enhances cell invasion in vitro, and this was reduced by
inhibiting NFAT (61). In addition, activating NFAT1
increased invasion of a breast cancer cell line, and this
response was COX-2 dependent (62). Furthermore,
NFAT2 has been shown to induce a transformed phe-
notype in fibroblasts (63). Our data suggest that NFAT
signaling may be worthy of further study in the context
of epidermal carcinogenesis in response to UVR.
CONCLUSIONS
We have demonstrated wavelength-dependent induction
of NFAT by UVR, with UVB wavelengths being potent
activators of NFAT. It is shown that inhibiting NFAT
signaling causes increased apoptosis following irradiation,
suggesting that UV-activated NFAT acts antiapoptotically
in keratinocytes. NFAT is involved in induction of COX-2
by UVR and like NFAT; COX-2 is induced more effec-
tively by UVB wavelengths. Taken together, our data
suggest that the proinflammatory and procarcinogenic
role played by COX-2 in response to UVR, may be
mediated, in part, by upstream NFAT signaling.
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